Aporte de la nutraceútica en el tratamiento integral de pacientes con cáncer de mama y cérvix.

Abstract

Breast and cervical cancer are two of the main causes of mortality in women globally, with a high incidence in middle- and low-income countries. Conventional treatments, such as chemotherapy and radiotherapy, although they are fundamental, are usually associated with significant adverse effects that impact the quality of life of patients. In this context, nutraceuticals have emerged as a promising complementary alternative due to their antioxidant, anti-inflammatory and immunomodulatory properties. This research, based on a systematic review of the literature, analyzes the impact of supplementation with bioactive compounds such as polyphenols, omega-3 fatty acids and vitamins in patients with breast and cervical cancer. The potential benefits in reducing adverse effects, improving the response to conventional therapies and their feasibility of implementation in the Ecuadorian context were evaluated. The results suggest that certain nutraceuticals may contribute to improving the quality of life of patients, although their effectiveness varies depending on the type of compound, dose and stage of the disease. Although the available evidence highlights the potential of nutraceuticals in integrative oncology, it is crucial to have more robust clinical studies to validate their efficacy and establish clinical use guidelines. Likewise, challenges in regulation, accessibility and education about its implementation are identified. This study provides a basis for future research and for the possible integration of nutritional strategies into cancer treatment.